Lung Cancer

Our expert lung cancer team works together to care for all types of cancer that affect the lungs and chest, including non-small cell lung cancer, small cell lung cancer, mesothelioma, and thymoma. We make every effort to ensure that your visits are as convenient as possible. You can often see multiple specialists on the same day, who collaborate to discuss your diagnosis and your entire care plan. You may be eligible to participate in clinical trials, which offer some of the newest therapies available.

Clinical Trials and Research Studies

Phase N/A

An Open-Label Multi-Center Global Study to Evaluate Long Term Safety and Efficacy in Patients Who are Receiving or Who Previously Received Durvalumab in Other Protocols (WAVE)

Learn More

Phase 2

An Open-Label Randomized Phase II Study of Combining Osimertinib with and without Ramucirumab in TKI-na ve EGFR-mutant Locally Advanced or Metastatic NSCLC

Learn More

Phase 2

The Selective Personalized Radio-Immunotherapy for locally advanced NSCLC Trial (SPRINT)

Learn More

Phase 3

Phase III randomized double-blind placebo-controlled multi-centre study assessing the efficacy and safety of durvalumab versus placebo as treatment following SBRT in patients with Stage I/II non small cell lung cancer.

Learn More